Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

The Clinical Impact of Psoas Muscle Cross-Sectional Area on Medium-Term Mortality After Transcatheter Aortic Valve Implantation.

Michel J, Pellegrini C, Rheude T, von Scheid M, Trenkwalder T, Elhmidi Y, Mayr NP, Brecker S, Kasel AM, Kastrati A, Schunkert H, Husser O, Bleiziffer S, Hengstenberg C.

Heart Lung Circ. 2019 May 23. pii: S1443-9506(19)30474-3. doi: 10.1016/j.hlc.2019.05.095. [Epub ahead of print]

PMID:
31182269
2.

Long-Term Durability of Transcatheter Aortic Valve Prostheses.

Blackman DJ, Saraf S, MacCarthy PA, Myat A, Anderson SG, Malkin CJ, Cunnington MS, Somers K, Brennan P, Manoharan G, Parker J, Aldalati O, Brecker SJ, Dowling C, Hoole SP, Dorman S, Mullen M, Kennon S, Jerrum M, Chandrala P, Roberts DH, Tay J, Doshi SN, Ludman PF, Fairbairn TA, Crowe J, Levy RD, Banning AP, Ruparelia N, Spence MS, Hildick-Smith D.

J Am Coll Cardiol. 2019 Feb 12;73(5):537-545. doi: 10.1016/j.jacc.2018.10.078.

PMID:
30732706
3.

Initial experience of a large, self-expanding, and fully recapturable transcatheter aortic valve: The UK & Ireland Implanters' registry.

Dowling C, Firoozi S, Doyle N, Blackman DJ, Malkin CJ, Cunnington MS, Saraf S, Buch MH, Levy R, Chowdhary S, Spence MS, Manoharan G, Owens CG, Brennan PF, Roberts D, More R, Wiper A, Abdelaziz HK, Mylotte D, Neylon A, Martin N, Mercanti F, Dorman S, Panoulas V, Dalby M, Kashyap MN, Kabir T, Kovac J, Kontoprias K, Malik IS, Ghada MW, Sen S, Ruparelia N, Demir OM, Frame A, Uren NG, Anderson R, Rajathurai T, Tapp L, Deegan L, Grech E, Hall I, Neville M, Rampat R, Hildick-Smith D, Mullen M, Kennon S, Chandrala P, Doshi S, Brecker SJ.

Catheter Cardiovasc Interv. 2019 Mar 1;93(4):751-757. doi: 10.1002/ccd.27934. Epub 2018 Nov 5.

PMID:
30394657
4.

A 'fluttering' diastolic murmur.

Dowling C, Firoozi S, Sharma R, Brecker SJ.

Eur Heart J Cardiovasc Imaging. 2018 Nov 1;19(11):1252. doi: 10.1093/ehjci/jey115. No abstract available.

PMID:
30113654
5.

Percutaneous coronary intervention for stable angina in ORBITA.

Dowling C, Firoozi S, Brecker S.

Lancet. 2018 Jul 7;392(10141):28. doi: 10.1016/S0140-6736(18)31209-1. Epub 2018 Jul 5. No abstract available.

PMID:
30047397
6.

Impact of Pre-Existing Prosthesis-Patient Mismatch on Survival Following Aortic Valve-in-Valve Procedures.

Pibarot P, Simonato M, Barbanti M, Linke A, Kornowski R, Rudolph T, Spence M, Moat N, Aldea G, Mennuni M, Iadanza A, Amrane H, Gaia D, Kim WK, Napodano M, Baumbach H, Finkelstein A, Kobayashi J, Brecker S, Don C, Cerillo A, Unbehaun A, Attias D, Nejjari M, Jones N, Fiorina C, Tchetche D, Philippart R, Spargias K, Hernandez JM, Latib A, Dvir D.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):133-141. doi: 10.1016/j.jcin.2017.08.039.

7.

Importance of Contrast Aortography With Lotus Transcatheter Aortic Valve Replacement: A Post Hoc Analysis From the RESPOND Post-Market Study.

van Gils L, Wöhrle J, Hildick-Smith D, Bleiziffer S, Blackman DJ, Abdel-Wahab M, Gerckens U, Brecker S, Bapat V, Modine T, Soliman OI, Nersesov A, Allocco D, Falk V, Van Mieghem NM.

JACC Cardiovasc Interv. 2018 Jan 22;11(2):119-128. doi: 10.1016/j.jcin.2017.10.016.

8.

Erratum to: Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):849. doi: 10.1007/s00392-017-1124-z. No abstract available.

PMID:
28676951
9.

Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.

Rampat R, Khawaja MZ, Hilling-Smith R, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS, Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D.

JACC Cardiovasc Interv. 2017 Jun 26;10(12):1247-1253. doi: 10.1016/j.jcin.2017.03.044.

10.

Final 5-year clinical and echocardiographic results for treatment of severe aortic stenosis with a self-expanding bioprosthesis from the ADVANCE Study.

Gerckens U, Tamburino C, Bleiziffer S, Bosmans J, Wenaweser P, Brecker S, Guo J, Linke A.

Eur Heart J. 2017 Sep 21;38(36):2729-2738. doi: 10.1093/eurheartj/ehx295.

11.

Insights on mid-term TAVR performance: 3-year clinical and echocardiographic results from the CoreValve ADVANCE study.

Bleiziffer S, Bosmans J, Brecker S, Gerckens U, Wenaweser P, Tamburino C, Linke A; ADVANCE Study Investigators.

Clin Res Cardiol. 2017 Oct;106(10):784-795. doi: 10.1007/s00392-017-1120-3. Epub 2017 May 8. Erratum in: Clin Res Cardiol. 2017 Jul 4;:.

PMID:
28484830
12.

Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.

Kalra SS, Firoozi S, Yeh J, Blackman DJ, Rashid S, Davies S, Moat N, Dalby M, Kabir T, Khogali SS, Anderson RA, Groves PH, Mylotte D, Hildick-Smith D, Rampat R, Kovac J, Gunarathne A, Laborde JC, Brecker SJ.

JACC Cardiovasc Interv. 2017 Feb 13;10(3):276-282. doi: 10.1016/j.jcin.2016.11.025.

13.

Transfemoral TAVI is superior to SAVR in elderly high-risk patients with symptomatic severe aortic stenosis!

Moat N, Brecker S.

Eur Heart J. 2016 Dec 14;37(47):3513-3514. doi: 10.1093/eurheartj/ehw382. Epub 2016 Sep 15. No abstract available.

PMID:
27634829
14.

Transcatheter Replacement of Failed Bioprosthetic Valves: Large Multicenter Assessment of the Effect of Implantation Depth on Hemodynamics After Aortic Valve-in-Valve.

Simonato M, Webb J, Kornowski R, Vahanian A, Frerker C, Nissen H, Bleiziffer S, Duncan A, Rodés-Cabau J, Attizzani GF, Horlick E, Latib A, Bekeredjian R, Barbanti M, Lefevre T, Cerillo A, Hernández JM, Bruschi G, Spargias K, Iadanza A, Brecker S, Palma JH, Finkelstein A, Abdel-Wahab M, Lemos P, Petronio AS, Champagnac D, Sinning JM, Salizzoni S, Napodano M, Fiorina C, Marzocchi A, Leon M, Dvir D.

Circ Cardiovasc Interv. 2016 Jun;9(6). pii: e003651. doi: 10.1161/CIRCINTERVENTIONS.115.003651.

PMID:
27301396
15.

Impact of Anesthesia Type on Outcomes of Transcatheter Aortic Valve Implantation (from the Multicenter ADVANCE Study).

Brecker SJ, Bleiziffer S, Bosmans J, Gerckens U, Tamburino C, Wenaweser P, Linke A; ADVANCE Study Investigators.

Am J Cardiol. 2016 Apr 15;117(8):1332-8. doi: 10.1016/j.amjcard.2016.01.027. Epub 2016 Jan 28.

PMID:
26892451
16.

Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Valve: United Kingdom Experience.

Rampat R, Khawaja MZ, Byrne J, MacCarthy P, Blackman DJ, Krishnamurthy A, Gunarathne A, Kovac J, Banning A, Kharbanda R, Firoozi S, Brecker S, Redwood S, Bapat V, Mullen M, Aggarwal S, Manoharan G, Spence MS, Khogali S, Dooley M, Cockburn J, de Belder A, Trivedi U, Hildick-Smith D.

JACC Cardiovasc Interv. 2016 Feb 22;9(4):367-372. doi: 10.1016/j.jcin.2015.12.012.

17.

Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study).

Barbanti M, Schiltgen M, Verdoliva S, Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Gulino S, Tamburino C, Linke A; ADVANCE Study Investigators.

Am J Cardiol. 2016 Mar 1;117(5):820-7. doi: 10.1016/j.amjcard.2015.11.066. Epub 2015 Dec 13.

PMID:
26762727
18.

Transcatheter Aortic Valve Replacement in a Patient With a Single Coronary Artery: Use of a Recapturable System.

Kalra SS, Firoozi S, Laborde JC, Brecker SJ.

J Interv Cardiol. 2016 Feb;29(1):124. doi: 10.1111/joic.12252. Epub 2016 Jan 5. No abstract available.

PMID:
26728115
19.

Treatment of Symptomatic Severe Aortic Stenosis With a Novel Resheathable Supra-Annular Self-Expanding Transcatheter Aortic Valve System.

Manoharan G, Walton AS, Brecker SJ, Pasupati S, Blackman DJ, Qiao H, Meredith IT.

JACC Cardiovasc Interv. 2015 Aug 24;8(10):1359-67. doi: 10.1016/j.jcin.2015.05.015.

20.

The Incidence and Predictors of Early- and Mid-Term Clinically Relevant Neurological Events After Transcatheter Aortic Valve Replacement in Real-World Patients.

Bosmans J, Bleiziffer S, Gerckens U, Wenaweser P, Brecker S, Tamburino C, Linke A; ADVANCE Study Investigators.

J Am Coll Cardiol. 2015 Jul 21;66(3):209-217. doi: 10.1016/j.jacc.2015.05.025.

21.

Transcatheter aortic valve implantation in patients with pre-existing chronic kidney disease.

Rahman MS, Sharma R, Brecker SJD.

Int J Cardiol Heart Vasc. 2015 Apr 22;8:9-18. doi: 10.1016/j.ijcha.2015.04.006. eCollection 2015 Sep 1.

22.

Left ventricular remodeling after transcatheter aortic valve implantation: one-year follow-up study.

Zakkar M, Alassar A, Lopez-Perez M, Roy D, Brecker S, Sharma R, Jahangiri M.

Innovations (Phila). 2015 Jan-Feb;10(1):44-7. doi: 10.1097/IMI.0000000000000122.

PMID:
25643301
23.

Cost-utility of transcatheter aortic valve implantation for inoperable patients with severe aortic stenosis treated by medical management: a UK cost-utility analysis based on patient-level data from the ADVANCE study.

Brecker S, Mealing S, Padhiar A, Eaton J, Sculpher M, Busca R, Bosmans J, Gerckens UJ, Wenaweser P, Tamburino C, Bleiziffer S, Piazza N, Moat N, Linke A.

Open Heart. 2014 Oct 23;1(1):e000155. doi: 10.1136/openhrt-2014-000155. eCollection 2014.

24.

Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.

Dvir D, Webb JG, Bleiziffer S, Pasic M, Waksman R, Kodali S, Barbanti M, Latib A, Schaefer U, Rodés-Cabau J, Treede H, Piazza N, Hildick-Smith D, Himbert D, Walther T, Hengstenberg C, Nissen H, Bekeredjian R, Presbitero P, Ferrari E, Segev A, de Weger A, Windecker S, Moat NE, Napodano M, Wilbring M, Cerillo AG, Brecker S, Tchetche D, Lefèvre T, De Marco F, Fiorina C, Petronio AS, Teles RC, Testa L, Laborde JC, Leon MB, Kornowski R; Valve-in-Valve International Data Registry Investigators.

JAMA. 2014 Jul;312(2):162-70. doi: 10.1001/jama.2014.7246.

25.

Treatment of aortic stenosis with a self-expanding transcatheter valve: the International Multi-centre ADVANCE Study.

Linke A, Wenaweser P, Gerckens U, Tamburino C, Bosmans J, Bleiziffer S, Blackman D, Schäfer U, Müller R, Sievert H, Søndergaard L, Klugmann S, Hoffmann R, Tchétché D, Colombo A, Legrand VM, Bedogni F, lePrince P, Schuler G, Mazzitelli D, Eftychiou C, Frerker C, Boekstegers P, Windecker S, Mohr FW, Woitek F, Lange R, Bauernschmitt R, Brecker S; ADVANCE study Investigators.

Eur Heart J. 2014 Oct 7;35(38):2672-84. doi: 10.1093/eurheartj/ehu162. Epub 2014 Mar 28.

26.

Survival, predictive factors, and causes of mortality following transcatheter aortic valve implantation.

Alassar A, Roy D, Valencia O, Brecker S, Jahangiri M.

Innovations (Phila). 2013 Sep-Oct;8(5):359-63. doi: 10.1097/IMI.0000000000000024.

PMID:
24346585
27.

Patent foramen ovale closure prior to surgery in the sitting position.

Laban JT, Rasul FT, Brecker SJ, Marsh HT, Martin AJ.

Br J Neurosurg. 2014 Jun;28(3):421-2. doi: 10.3109/02688697.2013.865709. Epub 2013 Dec 5.

PMID:
24304266
28.

Native aortic valve regurgitation: transcatheter therapeutic options.

Roy D, Sharma R, Brecker SJ.

EuroIntervention. 2013 Sep 10;9 Suppl:S55-62. doi: 10.4244/EIJV9SSA11. Review.

PMID:
24025959
29.

Outcomes of transcatheter aortic valve implantation compared to surgical aortic valve replacement following previous surgery.

Jones SG, Abdulkareem NR, Williams F, Brecker S, Jahangiri M.

J Heart Valve Dis. 2013 Mar;22(2):204-8.

PMID:
23798209
30.

First-in-man use of aortic valve ultrasound for assessment of aortic valve anatomy pre- and post-transcatheter aortic valve implantation.

Roy DA, Bhamra-Ariza P, Asherson A, Sharma R, Jahangiri M, Brecker S.

JACC Cardiovasc Interv. 2013 Jun;6(6):634-5. doi: 10.1016/j.jcin.2012.11.019. No abstract available.

31.

Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation.

Roy DA, Schaefer U, Guetta V, Hildick-Smith D, Möllmann H, Dumonteil N, Modine T, Bosmans J, Petronio AS, Moat N, Linke A, Moris C, Champagnac D, Parma R, Ochala A, Medvedofsky D, Patterson T, Woitek F, Jahangiri M, Laborde JC, Brecker SJ.

J Am Coll Cardiol. 2013 Apr 16;61(15):1577-84. doi: 10.1016/j.jacc.2013.01.018. Epub 2013 Feb 20.

32.

Acute kidney injury after transcatheter aortic valve implantation: incidence, risk factors, and prognostic effects.

Alassar A, Roy D, Abdulkareem N, Valencia O, Brecker S, Jahangiri M.

Innovations (Phila). 2012 Nov-Dec;7(6):389-93. doi: 10.1097/IMI.0b013e3182814e43.

PMID:
23422799
33.

First-in-man assessment of a dedicated guidewire for transcatheter aortic valve implantation.

Roy DA, Laborde JC, Sharma R, Jahangiri M, Brecker SJ.

EuroIntervention. 2013 Jan 22;8(9):1019-25. doi: 10.4244/EIJV8I9A157.

34.

Transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: results from the global valve-in-valve registry.

Dvir D, Webb J, Brecker S, Bleiziffer S, Hildick-Smith D, Colombo A, Descoutures F, Hengstenberg C, Moat NE, Bekeredjian R, Napodano M, Testa L, Lefevre T, Guetta V, Nissen H, Hernández JM, Roy D, Teles RC, Segev A, Dumonteil N, Fiorina C, Gotzmann M, Tchetche D, Abdel-Wahab M, De Marco F, Baumbach A, Laborde JC, Kornowski R.

Circulation. 2012 Nov 6;126(19):2335-44. doi: 10.1161/CIRCULATIONAHA.112.104505. Epub 2012 Oct 10.

35.

Transcatheter aortic valve implantation in a patient with previous Starr-Edwards mitral valve prosthesis.

Rahman MS, Roy D, Brecker SJ.

Heart. 2013 Feb;99(3):217-8. doi: 10.1136/heartjnl-2012-302919. Epub 2012 Oct 4. No abstract available.

PMID:
23038790
36.

Complications at the time of transcatheter aortic valve implantation.

Laborde JC, Brecker SJ, Roy D, Jahangiri M.

Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):38-41. Review.

37.

Standalone balloon aortic valvuloplasty: indications and outcomes from the UK in the transcatheter valve era.

Khawaja MZ, Sohal M, Valli H, Dworakowski R, Pettit SJ, Roy D, Newton J, Schneider H, Manoharan G, Doshi S, Muir D, Roberts D, Nolan J, Gunning M, Densem C, Spence MS, Chowdhary S, Mahadevan VS, Brecker SJ, Maccarthy P, Mullen M, Stables RH, Prendergast BD, de Belder A, Thomas M, Redwood S, Hildick-Smith D.

Catheter Cardiovasc Interv. 2013 Feb;81(2):366-73. doi: 10.1002/ccd.24534.

PMID:
22730270
38.

Adult congenital heart disease interventions: recommendations from a joint working group of the British Congenital Cardiac Association, British Cardiovascular Intervention Society, and the British Cardiovascular Society.

Qureshi SA, Hildick-Smith D, de Giovanni J, Clift P, Stuart G, Henderson R, Brecker S, Hackett D, Ray S, de Belder M; British Congenital Cardiac Association; British Cardiovascular Intervention Society; British Cardiovascular Society.

Cardiol Young. 2013 Feb;23(1):68-74. doi: 10.1017/S1047951112000327. Epub 2012 May 15.

PMID:
22583564
39.

Upper gastrointestinal haemorrhage in the acute cardiac care setting: antiplatelets and endoscopy.

Musa SA, Brecker SJ, Rahman TM, Kang JY.

Scott Med J. 2012 May;57(2):88-91. doi: 10.1258/smj.2012.012006.

PMID:
22555229
40.

Early experience with the transaortic approach for transcatheter aortic valve implantation.

Soppa G, Roy D, Brecker S, Jahangiri M.

J Thorac Cardiovasc Surg. 2012 May;143(5):1225-7. doi: 10.1016/j.jtcvs.2011.10.082. Epub 2011 Dec 9. No abstract available.

41.

Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.

Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, Thomas M, Kovac J, Spyt T, MacCarthy PA, Wendler O, Hildick-Smith D, Davies SW, Trivedi U, Blackman DJ, Levy RD, Brecker SJ, Baumbach A, Daniel T, Gray H, Mullen MJ.

J Am Coll Cardiol. 2011 Nov 8;58(20):2130-8. doi: 10.1016/j.jacc.2011.08.050. Epub 2011 Oct 20.

42.

Complications of transcatheter aortic valve implantation: avoidance and management.

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, Maccarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N; UK TAVI collaborative.

EuroIntervention. 2011 Sep;7(5):621-8. doi: 10.4244/EIJV7I5A99. Review.

43.

Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative).

Khawaja MZ, Rajani R, Cook A, Khavandi A, Moynagh A, Chowdhary S, Spence MS, Brown S, Khan SQ, Walker N, Trivedi U, Hutchinson N, De Belder AJ, Moat N, Blackman DJ, Levy RD, Manoharan G, Roberts D, Khogali SS, Crean P, Brecker SJ, Baumbach A, Mullen M, Laborde JC, Hildick-Smith D.

Circulation. 2011 Mar 8;123(9):951-60. doi: 10.1161/CIRCULATIONAHA.109.927152. Epub 2011 Feb 21.

PMID:
21339482
44.

CoreValve transcatheter aortic valve implantation via the subclavian artery: comparison with the transfemoral approach.

Moynagh AM, Scott DJ, Baumbach A, Khavandi A, Brecker SJ, Laborde JC, Brown S, Chowdhary S, Saravanan D, Crean PA, Teehan S, Hildick-Smith D, Trivedi U, Khogali SS, Bhabra MS, Roberts DH, Morgan KP, Blackman DJ; UK CoreValve Collaborative.

J Am Coll Cardiol. 2011 Feb 1;57(5):634-5. doi: 10.1016/j.jacc.2010.08.642. No abstract available.

45.

Outcome of patients with aortic stenosis referred to a multidisciplinary meeting for transcatheter valve.

Jahangiri M, Laborde JC, Roy D, Williams F, Abdulkareem N, Brecker S.

Ann Thorac Surg. 2011 Feb;91(2):411-5. doi: 10.1016/j.athoracsur.2010.10.008.

PMID:
21256281
46.

Tools & techniques: transcatheter aortic valve implantation: transfemoral approach.

Himbert D, Roy D, Brecker S, Brochet E, Depoix JP, Radu C, Laborde JC, Vahanian A.

EuroIntervention. 2011 Jan;6(6):784-5. doi: 10.4244/EIJV6I6A133. Review. No abstract available.

PMID:
21205606
47.

Transcatheter aortic valve replacement for symptomatic severe aortic valve regurgitation.

Dhillon PS, Kakouros N, Brecker SJ.

Heart. 2010 May;96(10):810. doi: 10.1136/hrt.2009.190421. No abstract available.

PMID:
20448136
48.

The diagnostic and prognostic value of tissue Doppler imaging during dobutamine stress echocardiography in end-stage renal disease.

Sharma R, Mehta RL, Brecker SJ, Gaze DC, Gregson H, Streather CP, Collinson PO, Pellerin D.

Coron Artery Dis. 2009 May;20(3):230-7. doi: 10.1097/MCA.0b013e32832ac5eb.

PMID:
19387250
49.

The expert witness: the doctor's perspective.

Brecker SJ.

Heart. 2009 May;95(9):763-5. doi: 10.1136/hrt.2008.149740. No abstract available.

PMID:
19366718
50.

Myocardial stunning identified by using strain/strain rate imaging during dobutamine stress echocardiography in a rare late recurrence of Tako-Tsubo syndrome.

Chaparro-Muñoz M, Recio-Mayoral A, Kaski JC, Brecker S, Sutherland GR.

Int J Cardiol. 2010 Nov 5;145(1):e9-12. doi: 10.1016/j.ijcard.2008.12.095. Epub 2009 Jan 27.

PMID:
19171392

Supplemental Content

Loading ...
Support Center